| LATS tumor suppressor: a new governor of cellular homeostasis S Visser, X Yang Cell cycle 9 (19), 3892-3903, 2010 | 239 | 2010 |
| Tumour suppressor genes in chemotherapeutic drug response D Lai, S Visser-Grieve, X Yang Bioscience reports 32 (4), 361-374, 2012 | 149 | 2012 |
| Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray S Visser, X Yang Gene 449 (1-2), 22-29, 2010 | 66 | 2010 |
| LATS1 tumor suppressor is a novel actin-binding protein and negative regulator of actin polymerization S Visser-Grieve, Z Zhou, YM She, H Huang, TD Cyr, T Xu, X Yang Cell research 21 (10), 1513-1516, 2011 | 57 | 2011 |
| Human homolog of Drosophila expanded, hEx, functions as a putative tumor suppressor in human cancer cell lines independently of the Hippo pathway S Visser-Grieve, Y Hao, X Yang Oncogene 31 (9), 1189-1195, 2012 | 54 | 2012 |
| Targeting NK cell inhibitory receptors for precision multiple myeloma immunotherapy H Alfarra, J Weir, S Grieve, T Reiman Frontiers in immunology 11, 575609, 2020 | 43 | 2020 |
| Insulin activates the insulin receptor to downregulate the PTEN tumour suppressor J Liu, S Visser-Grieve, J Boudreau, B Yeung, S Lo, G Chamberlain, F Yu, ... Oncogene 33 (29), 3878-3885, 2014 | 39 | 2014 |
| Calpain genetic disruption and HSP90 inhibition combine to attenuate mammary tumorigenesis S Grieve, Y Gao, C Hall, J Hu, PA Greer Molecular and Cellular Biology, 2016 | 26 | 2016 |
| TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC S Grieve, G Wajnberg, M Lees, S Chacko, J Weir, N Crapoulet, T Reiman Blood Advances 3 (22), 3613-3625, 2019 | 25 | 2019 |
| Epidemiology, healthcare resource utilization, and mortality of asthma and COPD in COVID-19: a systematic literature review and meta-analyses DMG Halpin, AP Rabe, WJ Loke, S Grieve, P Daniele, S Hwang, ... Journal of asthma and allergy, 811-825, 2022 | 19 | 2022 |
| Nanoparticle surface-enhanced Raman spectroscopy as a noninvasive, label-free tool to monitor hematological malignancy S Grieve, N Puvvada, A Phinyomark, K Russell, A Murugesan, E Zed, ... Nanomedicine 16 (24), 2175-2188, 2021 | 9 | 2021 |
| Dose escalation patterns of advanced therapies in Crohn’s disease and ulcerative colitis: a systematic literature review R Panaccione, WJ Lee, R Clark, K Kligys, RI Campden, S Grieve, T Raine Advances in Therapy 40 (5), 2051-2081, 2023 | 6 | 2023 |
| NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma BE Kennedy, M Giacomantonio, JP Murphy, S Cutler, M Sadek, P Konda, ... Molecular Therapy-Oncolytics 24, 695-706, 2022 | 4 | 2022 |
| Immunohistochemical validation study of 15-gene biomarker panel predictive of benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: Analysis of JBR. 10 S Grieve, K Ding, J Moore, M Finniss, A Ray, M Lees, F Hossain, ... ESMO open 5 (2), e000679, 2020 | 4 | 2020 |
| MST1 downregulates TAZ tumor suppressor protein in multiple myeloma and is a potential therapeutic target SO Abegunde, S Grieve, H Alfarra, T Reiman Experimental Hematology 123, 34-45, 2023 | 3 | 2023 |
| SA64 Comparative Effectiveness of Bimekizumab in Patients with Psoriatic Arthritis: Results from a Systematic Literature Review and Network Meta-Analysis PJ Mease, DD Gladman, JF Merola, P Nash, S Grieve, V Laliman-Khara, ... Value in Health 26 (6), S408, 2023 | 2 | 2023 |
| Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis PJ Mease, DD Gladman, JF Merola, P Nash, S Grieve, V Laliman-Khara, ... Rheumatology, kead705, 2024 | 1 | 2024 |
| Plain language summary of a fingerprinting technique to monitor blood cancer I Savinova, A Fournier, S Grieve, KR Brunt Nanomedicine 17 (23), 1751-1756, 2022 | 1 | 2022 |
| LATS1 (Large Tumor Suppressor 1) S Visser-Grieve, HJJ van Rensburg, X Yang http://AtlasGeneticsOncology. org, 179, 2016 | 1 | 2016 |
| Elucidating calpain’s role in the breast cancer cell signalling network S Visser-Grieve, J Hu, P Greer BMC Proceedings 7 (Suppl 2), P66, 2013 | 1 | 2013 |
